BioSpace News Archive

BioMidwest

Micro-Tech Endoscopy Announces Enhanced EUS Needle

Micro-Tech Endoscopy launched an enhanced version of the company’s EUS needles: Areus FNA and Trident FNB.

October 21, 2021
·
3 min read
BioMidwest

Longbow Immunotherapy Launches ReACT, A Novel CAR-T Platform Targeting Solid Tumors

Longbow Immunotherapy, a newly formed biotech advancing solid tumor therapy, announced its formation and exclusive license of the ReACT platform from the Versiti Blood Research Institute.

October 21, 2021
·
2 min read
Pharm Country

Petros Pharmaceuticals to Participate at Upcoming Benzinga Conference and Interview Show

Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men’s health, announces today that President and Chief Commercial Officer Fady Boctor will participate in the following Benzinga events.

October 21, 2021
·
1 min read
Drug Development

Adial Announces Positive Pre-Clinical Data for Purnovate’s PNV-5030 as Drug Candidate for the Treatment of Pain

Adial Pharmaceuticals, Inc. today announced positive data in a pre-clinical model of pain reduction. Based on this positive data, Purnovate, Inc.

October 21, 2021
·
8 min read
Biotech Bay

RefleXion Highlights New Cancer Treatment Research at ASTRO 2021

RefleXion Medical, today announced multiple clinical abstracts evaluating the potential use and utility of its novel technology were accepted for presentation during the American Society for Radiation Oncology (ASTRO) 2021 Annual Meeting, Oct. 24-27, in Chicago.

October 21, 2021
·
3 min read
Drug Development

Adial Announces Positive Pre-Clinical Data for Purnovate’s PNV-5030 as a Drug Candidate for the Treatment of Pain

Adial Pharmaceuticals, Inc. today announced positive data in a pre-clinical model of pain reduction. Based on this positive data, Purnovate, Inc.

October 21, 2021
·
8 min read
Drug Development

Tryp Therapeutics Reports Clinical Hold on Proposed Phase 2a Study in Eating Disorders

The notification from the FDA did not provide a reason for the clinical hold and advised that the FDA would provide additional details any deficiencies within 30 days.

October 21, 2021
·
4 min read
Pharm Country

Progress in Xenotransplantation Opens Door to New Supply of Critically Needed Organs

The first investigational transplantation of a genetically engineered, nonhuman kidney to a human body was recently completed at NYU Langone Health—marking a major step forward in potentially utilizing an alternative supply of organs for people facing life-threatening disease.

October 21, 2021
·
5 min read
BioMidwest

Research Reveals Trivalent PROTACs More Potent in Targeted Protein Degradation

Researchers from the University of Dundee and Promega Corporation have shown how a “three-headed hydra” significantly improves efficacy in targeted protein degradation.

October 21, 2021
·
5 min read
Business

Universities and DENSO Develop Biosensor to Detect SARS-CoV-2 and Accelerate Development for practical application

Tokai University, Toyohashi University of Technology, Chubu University, and DENSO Corporation have been developing testing equipment to detect SARS-CoV-2 with support from the Japan Agency for Medical Research and Development (AMED)*1.

October 21, 2021
·
4 min read